Core Insights - The company, Ruimait, closed at 86.84 yuan on July 28, with a decline of 2.42%, resulting in a rolling PE ratio of 43.86 times and a total market capitalization of 7.781 billion yuan [1] - In the medical device industry, the average PE ratio is 55.28 times, with a median of 38.06 times, placing Ruimait at the 81st position in the industry ranking [1] - The company experienced a net inflow of 1.0641 million yuan in principal funds on July 28, but overall, there was a net outflow of 45.7513 million yuan over the past five days [1] Company Overview - Ruimait specializes in manufacturing medical devices and consumables in the field of respiratory health, with key products including various types of sleep breathing machines and monitoring devices [1] - The company holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, as well as 202 international patents across various countries [1] Financial Performance - In the first quarter of 2025, the company reported an operating income of 265 million yuan, representing a year-on-year increase of 38.11%, and a net profit of 71.9314 million yuan, up 44.11% year-on-year, with a gross profit margin of 49.57% [2] - The company's PE ratio (TTM) stands at 43.86, while the industry average is 55.28, indicating a relatively lower valuation compared to peers [2]
瑞迈特收盘下跌2.42%，滚动市盈率43.86倍，总市值77.81亿元